Disopyramide Phosphate Capsule, Extended Release shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-08-24 · last update 2026-08-24
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 08/24/2026 Updated 08/24/2026 Discontinued 08/24/2026 |
| Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 08/24/2026 Updated 08/24/2026 Discontinued 08/24/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)